Personalised in vitro model to help screen drugs for kidney cancer
Researchers at the University of Wisconsin Carbone Cancer Center in [...]
The hunt for a kidney cancer biomarker reveals two more potential candidates
As the hunt for a reliable biomarker for renal cell [...]
Anlotinib versus sunitinib as first-line treatment for metastatic kidney cancer
The results of a recent phase 2 study to evaluate [...]
Even when the stakes are high, patients with cancer don’t always take their medications
This interesting article was published online in Cancer Therapy Advisor, [...]
Potential biomarkers for kidney cancer
Two recent studies have identified potential biomarkers for renal cell [...]
Prognosis of kidney cancer with bone metastases
A recent study, published in the European Journal of Cancer, [...]
Predicting response to immunotherapy
Some patients have impressive and long-lasting responses to immune checkpoint [...]
Carrying extra weight during adolescence is associated with increased later risk of kidney cancer
A recent study from Sweden published in the International Journal [...]
EAU 2019
The European Association of Urology (EAU) held its annual congress [...]
Hand-foot syndrome as a predictor of better outcomes in patients treated with sunitinib
A recent study, published in the journal Advances in Medicine [...]
